Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 83, Iss. 5, pp. 975-991
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

TGFβ biology in cancer progression and immunotherapy
Rik Derynck, Shannon J. Turley, Rosemary J. Akhurst
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 1, pp. 9-34
Open Access | Times Cited: 649
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
Yunzhen Qian, Yitao Gong, Zhiyao Fan, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 250
Steps in metastasis: an updated review
Jamal Majidpoor, Keywan Mortezaee
Medical Oncology (2021) Vol. 38, Iss. 1
Closed Access | Times Cited: 213
Clinical development of therapies targeting TGFβ: current knowledge and future perspectives
Davide Ciardiello, Elena Élez, Josep Tabernero, et al.
Annals of Oncology (2020) Vol. 31, Iss. 10, pp. 1336-1349
Open Access | Times Cited: 201
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 140
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
Davide Melisi, Do‐Youn Oh, Antoine Hollebecque, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e002068-e002068
Open Access | Times Cited: 133
Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities
Zhao Huang, Zhe Zhang, Chengwei Zhou, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 94
Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy
Jiaqiang Xiong, Rourou Xiao, Jiahui Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Cancer-Associated Fibroblasts: Understanding Their Heterogeneity
Kévin Louault, Rongrong Li, Yves A. DeClerck
Cancers (2020) Vol. 12, Iss. 11, pp. 3108-3108
Open Access | Times Cited: 113
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
Nicholas C. DeVito, Michael P. Plebanek, Bala Theivanthiran, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 84
Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy
Haodi Zhao, Jing Wei, Jian Sun
International Immunopharmacology (2020) Vol. 89, pp. 107101-107101
Closed Access | Times Cited: 79
microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3
Jian Chang, Hanjun Li, Zhongchao Zhu, et al.
Cell Biology and Toxicology (2021) Vol. 38, Iss. 4, pp. 577-590
Open Access | Times Cited: 65
Trials and tribulations of pancreatic cancer immunotherapy
Daniel R. Principe, Murray Korc, Suneel D. Kamath, et al.
Cancer Letters (2021) Vol. 504, pp. 1-14
Open Access | Times Cited: 62
Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts
Huiqin Liu, Yu Shi, Feng Qian
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 37-51
Closed Access | Times Cited: 59
Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets
Shinelle Menezes, Mohamed Hazem Okail, Siti Munira Abd Jalil, et al.
The Journal of Pathology (2022) Vol. 257, Iss. 4, pp. 526-544
Open Access | Times Cited: 52
Fibroblasts in pancreatic cancer: molecular and clinical perspectives
Rita Rebelo, Cristina P. R. Xavier, Elisa Giovannetti, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 439-453
Closed Access | Times Cited: 41
TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity
Shafat Ali, Muneeb U. Rehman, Ali Mohd Yatoo, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175678-175678
Closed Access | Times Cited: 32
Context-dependent TGFβ family signalling in cell fate regulation
Louise Richardson, Scott G. Wilcockson, Luca Guglielmi, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 12, pp. 876-894
Closed Access | Times Cited: 23
Precision treatment of pancreatic ductal adenocarcinoma
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 9
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
TGF-β mediated drug resistance in solid cancer
Marta Turati, Alexandra Mousset, Nervana Issa, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 54-65
Open Access | Times Cited: 21
Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors
Morgan E. Lorkowski, Prabhani U. Atukorale, Peter A. Bielecki, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 1095-1105
Open Access | Times Cited: 49
A bird’s eye view of fibroblast heterogeneity: A pan‐disease, pan‐cancer perspective
Rachana Pradhan, Akshay T. Krishnamurty, Anne Fletcher, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 299-320
Closed Access | Times Cited: 40
Epithelial to Mesenchymal Transition History: From Embryonic Development to Cancers
Camille Lachat, Paul Peixoto, Éric Hervouet
Biomolecules (2021) Vol. 11, Iss. 6, pp. 782-782
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top